ClinicalThought

Share

Program Content

Activities

  • Advanced NSCLC Online Tool
    An Interactive Online Tool Featuring Expert Recommendations for Advanced NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 05, 2016

    Expires: August 04, 2017

  • Immune Checkpoint Blockade
    Immune Checkpoint Blockade in Advanced Lung Cancer Patients: Optimizing Treatment Duration
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 30, 2016

    Expires: September 29, 2017

  • NSCLC: New First-Line Option
    First-line Checkpoint Inhibitor Therapy in Metastatic NSCLC: A New Option for Our Patients
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 27, 2016

    Expires: October 26, 2017

  • Lung Cancer NOS Diagnoses
    Clinical Dilemma: A Patient With a Diagnosis of Stage IV NSCLC-NOS Is Referred to You for a Second Opinion
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 21, 2016

    Expires: November 20, 2017

  • Atezolizumab in NSCLC
    Atezolizumab: A New Treatment Option for Progressive Metastatic NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 20, 2016

    Expires: December 19, 2017

  • NSCLC in Elderly Patients
    Managing Elderly Patients With Advanced NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 30, 2017

    Expires: January 29, 2018

  • QoL in Advanced NSCLC
    Multidisciplinary Approaches to Maximize QoL in Patients With Advanced NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 07, 2017

    Expires: March 06, 2018

  • Pembrolizumab Plus CT for NSCLC
    Combination Immunotherapy Plus Chemotherapy as First-line Therapy of Advanced NSCLC: Where Are We Now?
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 11, 2017

    Expires: April 10, 2018

  • Rare Mutations in NSCLC
    Targeted Therapy Beyond EGFR, ALK, and ROS1: A New Frontier in NSCLC Care
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 10, 2017

    Expires: May 09, 2018

  • Triage of irAEs
    The Role of the Triage Nurse in Management of Immune-Related Adverse Events in NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 09, 2017

    Expires: June 08, 2018

  • First-line Alectinib for ALK+ NSCLC
    Alectinib: A New Standard of Care for Newly Diagnosed Advanced ALK-Positive NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 07, 2017

    Expires: July 06, 2018

  • NSCLC Molecular Profiling
    Have We Reached the Tipping Point for Broad Molecular Profiling in Advanced NSCLC?
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 09, 2017

    Expires: August 08, 2018

Faculty

cover img faculity

Michele S. Barber, MS, NP, AOCNP

Oncology Nurse Practitioner
Department of Hematology/Oncology
Lahey Health Hospital and Medical Center
Peabody, Massachusetts

cover img faculity

Miriam Blasingame, BSN, RN, OCN

Medical Oncology Nurse Clinician
Department of Medical Oncology
Baylor Scott and White McClinton Cancer Center
Waco, Texas

cover img faculity

David R. Gandara, MD

Professor of Clinical Medicine
Associate Director for Clinical Research
University of California Davis Cancer Center
Davis, California

cover img faculity

Leora Horn, MD, MSc

Assistant Professor, Hematology Oncology/Medicine
Vanderbilt Ingram Cancer Center
Vanderbilt University
Nashville, Tennessee

cover img faculity

Heather J. Jackson, PhD, FNP-BC, NEA-BC, FAANP

Associate Professor
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University School of Nursing
Administrative Director of Advanced Practice
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

cover img faculity

Melissa L. Johnson, MD

Assistant Professor
Division of Hematology/Oncology
Robert H. Lurie Comprehensive Cancer Center 
Northwestern University
Assistant Attending
Divison of Hematology/Oncology
Northwestern Memorial Hospital
Chicago, Illinois

cover img faculity

Naiyer Rizvi, MD

Professor of Medicine
Price Chair of Thoracic Translational Oncology

Director of Thoracic Oncology
Director of Immuno-Oncology
Columbia University Medical Center
New York, New York

cover img faculity

Alice Shaw, MD, PhD

Associate Professor of Medicine
Harvard Medical School
Director, Center for Thoracic Centers
Paula OKeefe Endowed Chair in Thoracic Oncology
MGH Cancer Center/Center for Thoracic Cancers
Massachusetts General Hospital
Boston, Massachusetts

cover img faculity

Thomas Stinchcombe, MD

Medical Oncologist
Thoracic Oncology Program
Duke University Medical Center
Durham, North Carolina

cover img faculity

Jared Weiss, MD

Assistant Professor of Medicine
Attending Physician

Department of Hematology and Oncology
University of North Carolina
Chapel Hill, North Carolina

Provided by

ProCE Banner

Supporters

AbbVie

Celgene

Genentech Roche Virology

Lilly

Merck Oncology

Novartis Pharmaceuticals Corporation